News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Gilead Sciences, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Biotech Bay
Gilead: A Poor Payback Period For Kite Pharma?
September 12, 2017
·
1 min read
Biotech Bay
5 Things Gilead’ Management Just Said That You’ll Want To Know
September 7, 2017
·
1 min read
Deals
How Gilead and Kite Pharma’s Flirtation Became the Real Thing
September 6, 2017
·
3 min read
Biotech Bay
Why Is Gilead On Fire?
September 1, 2017
·
1 min read
Deals
Can Gilead Squeeze $12 Billion From Kite Pharma?
August 30, 2017
·
1 min read
Deals
Why Gilead Could Take Out Juno But Face Major Competition From This Biotech Giant
August 30, 2017
·
2 min read
Deals
Gilead And Kite Pharma. A $12 Billion Deal. One More Pricey Drug.
August 29, 2017
·
1 min read
Business
Gilead Goes Big, Pays $11.9 Billion for This SoCal CAR-T Biopharma
August 28, 2017
·
3 min read
Deals
Why Gilead Might Not Make an Oncology Buy After All
August 16, 2017
·
3 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Repare Therapeutics Announces Acquisition of Polθ ATPase Inhibitor, RP-3467, by Gilead Sciences for Up To $30 Million in Total Consideration
December 25, 2025
·
8 min read
Press Releases
Gilead Sciences to Present at Upcoming Investor Conference
December 23, 2025
·
1 min read
Press Releases
Gilead Sciences Exercises Option to License Assembly Biosciences’ Helicase-Primase Inhibitor Programs for Recurrent Genital Herpes
December 23, 2025
·
8 min read
Press Releases
Faron Announces Strategic Collaboration with The Institute for Cancer Research to Launch BLAZE Trial, Targeting Immunotherapy Resistance in Cancer
December 22, 2025
·
5 min read
Press Releases
Gilead and U.S. Government Enter Agreement to Lower Costs of Medicines for Americans
December 22, 2025
·
5 min read
Press Releases
Gilead Sciences Appoints Keeley Wettan as Executive Vice President, General Counsel, Legal & Compliance
December 19, 2025
·
2 min read
Press Releases
Gilead’s Investigational Single-Tablet Regimen of Bictegravir and Lenacapavir for HIV Treatment Meets Primary Endpoint in Phase 3 ARTISTRY-2 Trial
December 16, 2025
·
9 min read
Press Releases
Arcus Provides Update on Phase 3 STAR-221 Study and Concentrates Its R&D Investment on Casdatifan and Emerging Inflammation and Immunology Portfolio
December 15, 2025
·
13 min read
Press Releases
Gilead Foundation Awards Over $3 Million to Support People Living With Metastatic Breast Cancer
December 10, 2025
·
4 min read
Press Releases
Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Studies of Long-Acting Helicase-Primase Inhibitor Candidates ABI-1179 and ABI-5366 Showing Reductions in Viral Shedding Rate and Virologically Confirmed Genital Lesion Rate in Recurrent Genital Herpes
December 9, 2025
·
19 min read
